Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Archive
- 2026/Volume 47
- 2025/Volume 46
- 2024/Volume 45
- 2023/Volume 44
- 2022/Volume 43
- 2021/Volume 42
- 2020/Volume 41
- 2019/Volume 40
- 2018/Volume 39
- 2017/Volume 38
- 2016/Volume 37
- 2015/Volume 36
- 2014/Volume 35
- 2013/Volume 34
- 2012/Volume 33
- 2011/Volume 32
- 2011/Volume 31
- 2009/Volume 30
- 2008/Volume 29
- 2007/Volume 28
- 2006/Volume 27
- 2005/Volume 26
- 2004/Volume 25
- 2003/Volume 24
- 2002/Volume 23
- 2001/Volume 22
- 2000/Volume 21
Vol.22,Issue 4,July 2001
Reviews
Heat shock protein expression and immunity: relevance to gynecologic oncology
Heat shock protein expression and immunity: relevance to gynecologic oncology
DOI: 10.12892/ejgo200104249
Abstract ( 1671 ) PDF (933.24 kB) ( 116 ) Full Text
Non diethy lstilbesterol induced vaginal adenosis-A case series and review of literature
Non diethy lstilbesterol induced vaginal adenosis-A case series and review of literature
DOI: 10.12892/ejgo200104260
Abstract ( 1631 ) PDF (343.19 kB) ( 112 ) Full Text
Sclerosing stromal tumor of the ovary: A case report and review of the literature
Sclerosing stromal tumor of the ovary: A case report and review of the literature
DOI: 10.12892/ejgo200104300
Abstract ( 2578 ) PDF (5.58 MB) ( 140 ) Full Text
Original Research
The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents
The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents
DOI: 10.12892/ejgo200104266
Abstract ( 1439 ) PDF (406.42 kB) ( 111 ) Full Text
Can intermediate-risk node-negative patients with stage I corpus cancer do without posthysterectomy radiotherapy? Review of a 13-year experience
Can intermediate-risk node-negative patients with stage I corpus cancer do without posthysterectomy radiotherapy? Review of a 13-year experience
DOI: 10.12892/ejgo200104269
Abstract ( 1483 ) PDF (466.97 kB) ( 116 ) Full Text
Chemosensitivity testing predicts survival in ovarian cancer
Chemosensitivity testing predicts survival in ovarian cancer
DOI: 10.12892/ejgo200104278
Abstract ( 1535 ) PDF (701.79 kB) ( 146 ) Full Text
Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study
Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study
DOI: 10.12892/ejgo200104287
Abstract ( 1611 ) PDF (587.06 kB) ( 129 ) Full Text
Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovanan carcinomas
Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovanan carcinomas
DOI: 10.12892/ejgo200104292
Abstract ( 1722 ) PDF (5.15 MB) ( 120 ) Full Text
Organ preserving method in the management of atypical endometrial hyperplasia
Organ preserving method in the management of atypical endometrial hyperplasia
DOI: 10.12892/ejgo200104297
Abstract ( 1463 ) PDF (330.43 kB) ( 111 ) Full Text
Minor prognostic factors in squamous cell vulvar carcinoma
Minor prognostic factors in squamous cell vulvar carcinoma
DOI: 10.12892/ejgo200104305
Abstract ( 1613 ) PDF (469.13 kB) ( 109 ) Full Text
Case Reports
Cauda equina compression in breast cancer -incidence and treatment outcome
Cauda equina compression in breast cancer -incidence and treatment outcome
DOI: 10.12892/ejgo200104257
Abstract ( 2091 ) PDF (1.59 MB) ( 113 ) Full Text
Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: A case report
Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: A case report
DOI: 10.12892/ejgo200104263
Abstract ( 1460 ) PDF (3.29 MB) ( 101 ) Full Text
Successful treatment of a persistent mole with myometrial invasion by direct injection of methotrexate
Successful treatment of a persistent mole with myometrial invasion by direct injection of methotrexate
DOI: 10.12892/ejgo200104283
Abstract ( 1592 ) PDF (5.96 MB) ( 107 ) Full Text
